易方达标普生物科技指数证券投资基金(LOF)A类人民币(161127)
十大重仓股
- 2023年
- 2022年
- 2021年
- 2020年
2023年3季度
| 序号 | 股票代码 | 股票名称 | 数量（股） | 公允价值（元） | 占基金资产净值比例（%） |
|---|---|---|---|---|---|
| 1 | IMVT US | Immunovant Inc | 15,245 | 4,202,017.80 | 1.56 |
| 2 | MRTX US | Mirati Therapeutics Inc | 12,823 | 4,010,420.02 | 1.49 |
| 3 | IONS US | Ionis Pharmaceuticals Inc | 11,096 | 3,613,697.88 | 1.34 |
| 4 | SGEN US | Seagen Inc | 2,237 | 3,407,386.25 | 1.27 |
| 5 | AKRO US | Akero Therapeutics Inc | 9,428 | 3,423,818.59 | 1.27 |
| 6 | NBIX US | Neurocrine Biosciences Inc | 4,185 | 3,380,339.59 | 1.26 |
| 7 | AMGN US | 安进公司 | 1,763 | 3,401,960.69 | 1.26 |
| 8 | VRTX US | 福泰制药 | 1,333 | 3,328,105.97 | 1.24 |
| 9 | IMGN US | 英基股份有限公司 | 29,125 | 3,318,602.28 | 1.23 |
| 10 | SRPT US | Sarepta Therapeutics Inc | 3,814 | 3,319,459.05 | 1.23 |
2023年2季度
| 序号 | 股票代码 | 股票名称 | 数量（股） | 公允价值（元） | 占基金资产净值比例（%） |
|---|---|---|---|---|---|
| 1 | CPRX US | Catalyst Pharmaceuticals Inc | 38,438 | 3,732,896.84 | 1.18 |
| 2 | BBIO US | Bridgebio Pharma Inc | 27,916 | 3,469,505.44 | 1.10 |
| 3 | BPMC US | Blueprint Medicines Corp | 7,639 | 3,488,506.41 | 1.10 |
| 4 | EXAS US | Exact Sciences Corp | 5,087 | 3,451,542.83 | 1.09 |
| 5 | HALO US | Halozyme Therapeutics Inc | 13,152 | 3,427,866.34 | 1.09 |
| 6 | VRTX US | 福泰制药 | 1,337 | 3,399,765.42 | 1.08 |
| 7 | RVMD US | REVOLUTION Medicines Inc | 17,469 | 3,376,585.63 | 1.07 |
| 8 | HZNP US | Horizon Therapeutics Plc | 4,501 | 3,345,024.06 | 1.06 |
| 9 | ISEE US | IVERIC bio Inc | 11,717 | 3,330,709.24 | 1.05 |
| 10 | INCY US | 因赛特公司 | 7,318 | 3,291,680.67 | 1.04 |
2023年1季度
| 序号 | 股票代码 | 股票名称 | 数量（股） | 公允价值（元） | 占基金资产净值比例（%） |
|---|---|---|---|---|---|
| 1 | VKTX US | Viking Therapeutics Inc | 30,676 | 3,509,757.88 | 1.22 |
| 2 | SGEN US | Seagen Inc | 2,238 | 3,113,758.72 | 1.08 |
| 3 | EXEL US | Exelixis Inc | 23,153 | 3,088,140.12 | 1.07 |
| 4 | FATE US | Fate Therapeutics Inc | 79,137 | 3,099,692.62 | 1.07 |
| 5 | CPRX US | Catalyst Pharmaceuticals Inc | 26,379 | 3,005,432.96 | 1.04 |
| 6 | ISEE US | IVERIC bio Inc | 17,913 | 2,994,846.90 | 1.04 |
| 7 | MRNA US | Moderna Inc | 2,793 | 2,947,608.43 | 1.02 |
| 8 | REGN US | Regeneron Pharmaceuticals Inc | 517 | 2,919,121.46 | 1.01 |
| 9 | RCUS US | Arcus Biosciences Inc | 23,335 | 2,924,804.42 | 1.01 |
| 10 | VRTX US | Vertex Pharmaceuticals Inc | 1,345 | 2,912,014.47 | 1.01 |
2022年4季度
| 序号 | 股票代码 | 股票名称 | 数量（股） | 公允价值（元） | 占基金资产净值比例（%） |
|---|---|---|---|---|---|
| 1 | MDGL US | Madrigal Pharmaceutical s Inc | 5,532 | 11,182,800.53 | 3.45 |
| 2 | ARWR US | Arrowhead Pharmaceutical s Inc | 13,978 | 3,948,563.81 | 1.22 |
| 3 | CYTK US | Cytokinetics Inc | 11,806 | 3,767,506.78 | 1.16 |
| 4 | AKRO US | Akero Therapeutics Inc | 9,604 | 3,665,463.41 | 1.13 |
| 5 | ALT US | Altimmune Inc | 31,286 | 3,584,364.12 | 1.11 |
| 6 | HZNP US | Horizon Therapeutics Plc | 4,346 | 3,444,515.65 | 1.06 |
| 7 | RARE US | Ultragenyx Pharmaceutical Inc | 10,398 | 3,355,121.81 | 1.03 |
| 8 | CPRX US | Catalyst Pharmaceutical s Inc | 25,814 | 3,343,985.83 | 1.03 |
| 9 | PCVX US | Vaxcyte Inc | 9,933 | 3,317,150.88 | 1.02 |
| 10 | EXAS US | Exact Sciences Corp | 9,481 | 3,269,213.26 | 1.01 |
2022年3季度
| 序号 | 股票代码 | 股票名称 | 数量（股） | 公允价值（元） | 占基金资产净值比例（%） |
|---|---|---|---|---|---|
| 1 | BIIB US | Biogen Inc | 2,248 | 4,261,413.56 | 1.31 |
| 2 | APLS US | Apellis Pharmaceuticals Inc | 7,050 | 3,418,660.20 | 1.05 |
| 3 | SWTX US | SpringWorks Therapeutics Inc | 16,803 | 3,403,570.21 | 1.05 |
| 4 | NBIX US | Neurocrine Biosciences Inc | 4,473 | 3,372,954.03 | 1.04 |
| 5 | GBT US | Global Blood Therapeutics Inc | 7,030 | 3,398,979.55 | 1.04 |
| 6 | CCXI US | ChemoCentryx Inc | 9,252 | 3,393,408.48 | 1.04 |
| 7 | BHVN US | Biohaven Ltd | 3,160 | 3,391,554.58 | 1.04 |
| 8 | VRTX US | Vertex Pharmaceuticals Inc | 1,631 | 3,352,807.71 | 1.03 |
| 9 | CRSP US | CRISPR Therapeutics AG | 7,113 | 3,300,232.34 | 1.01 |
| 10 | ISEE US | IVERIC bio Inc | 25,624 | 3,263,739.44 | 1.00 |
2022年2季度
| 序号 | 股票代码 | 股票名称 | 数量（股） | 公允价值（元） | 占基金资产净值比例（%） |
|---|---|---|---|---|---|
| 1 | GBT US | Global Blood Therapeutics Inc | 19,349 | 4,148,991.17 | 1.38 |
| 2 | IOVA US | Iovance Biotherapeutics Inc | 52,755 | 3,908,821.37 | 1.30 |
| 3 | TWST US | Twist Bioscience Corp | 16,351 | 3,836,444.02 | 1.27 |
| 4 | FOLD US | Amicus Therapeutics Inc | 52,439 | 3,779,825.98 | 1.26 |
| 5 | SGEN US | Seagen Inc | 3,142 | 3,731,172.49 | 1.24 |
| 6 | NVAX US | Novavax Inc | 10,780 | 3,720,903.52 | 1.24 |
| 7 | FATE US | Fate Therapeutics Inc | 22,103 | 3,675,916.60 | 1.22 |
| 8 | KRTX US | Karuna Therapeutics Inc | 4,316 | 3,664,539.57 | 1.22 |
| 9 | PTCT US | PTC Therapeutics Inc | 13,553 | 3,643,841.74 | 1.21 |
| 10 | NTLA US | Intellia Therapeutics Inc | 10,315 | 3,583,245.99 | 1.19 |
2022年1季度
| 序号 | 股票代码 | 股票名称 | 数量（股） | 公允价值（元） | 占基金资产净值比例（%） |
|---|---|---|---|---|---|
| 1 | OCGN US | Ocugen Inc | 109,488 | 2,293,670.68 | 1.09 |
| 2 | IOVA US | Iovance Biotherapeutics Inc | 20,353 | 2,151,261.83 | 1.02 |
| 3 | EDIT US | Editas Medicine Inc | 17,812 | 2,150,670.11 | 1.02 |
| 4 | GBT US | Global Blood Therapeutics Inc | 9,646 | 2,121,171.30 | 1.01 |
| 5 | MRNA US | Moderna Inc | 1,941 | 2,122,562.95 | 1.01 |
| 6 | KRTX US | Karuna Therapeutics Inc | 2,607 | 2,098,343.74 | 0.99 |
| 7 | CDNA US | CareDx Inc | 8,715 | 2,046,455.59 | 0.97 |
| 8 | ARCT US | Arcturus Therapeutics Holdings Inc | 11,910 | 2,038,366.39 | 0.97 |
| 9 | BBIO US | Bridgebio Pharma Inc | 31,264 | 2,014,471.77 | 0.96 |
| 10 | NTLA US | Intellia Therapeutics Inc | 4,377 | 2,019,213.81 | 0.96 |
2021年4季度
| 序号 | 股票代码 | 股票名称 | 数量（股） | 公允价值（元） | 占基金资产净值比例（%） |
|---|---|---|---|---|---|
| 1 | ARNA US | Arena Pharmaceuticals Inc | 3,473 | 2,057,952.40 | 1.36 |
| 2 | BHVN US | Biohaven Pharmaceutical Holding Co Ltd | 1,739 | 1,527,946.64 | 1.01 |
| 3 | CYTK US | Cytokinetics Inc | 4,804 | 1,396,063.57 | 0.92 |
| 4 | TPTX US | Turning Point Therapeutics Inc | 4,366 | 1,327,791.81 | 0.88 |
| 5 | BCRX US | BioCryst Pharmaceuticals Inc | 14,885 | 1,314,396.78 | 0.87 |
| 6 | FATE US | Fate Therapeutics Inc | 3,528 | 1,316,092.91 | 0.87 |
| 7 | HALO US | Halozyme Therapeutics Inc | 5,027 | 1,288,756.39 | 0.85 |
| 8 | KYMR US | Kymera Therapeutics Inc | 3,150 | 1,275,098.56 | 0.84 |
| 9 | TGTX US | TG Therapeutics Inc | 10,466 | 1,267,833.45 | 0.84 |
| 10 | UTHR US | United Therapeutics Corp | 920 | 1,267,448.36 | 0.84 |
2021年3季度
| 序号 | 股票代码 | 股票名称 | 数量（股） | 公允价值（元） | 占基金资产净值比例（%） |
|---|---|---|---|---|---|
| 1 | XLRN US | Acceleron Pharma Inc | 1,302 | 1,453,210.82 | 0.93 |
| 2 | CYTK US | Cytokinetics Inc | 5,840 | 1,353,643.06 | 0.87 |
| 3 | SRPT US | Sarepta Therapeutics Inc | 2,142 | 1,284,706.89 | 0.82 |
| 4 | TGTX US | TG Therapeutics Inc | 5,786 | 1,248,816.17 | 0.80 |
| 5 | SGEN US | Seagen Inc | 1,138 | 1,253,189.41 | 0.80 |
| 6 | CCXI US | ChemoCentryx Inc | 11,179 | 1,239,754.90 | 0.80 |
| 7 | MCRB US | Seres Therapeutics Inc | 27,492 | 1,240,944.45 | 0.80 |
| 8 | DVAX US | Dynavax Technologies Corp | 9,823 | 1,223,793.88 | 0.79 |
| 9 | IOVA US | Iovance Biotherapeutics Inc | 7,571 | 1,210,829.76 | 0.78 |
| 10 | MRTX US | Mirati Therapeutics Inc | 1,045 | 1,198,962.06 | 0.77 |
2021年2季度
| 序号 | 股票代码 | 股票名称 | 数量（股） | 公允价值（元） | 占基金资产净值比例（%） |
|---|---|---|---|---|---|
| 1 | NTLA US | Intellia Therapeutics Inc | 1,884 | 1,970,578.83 | 1.12 |
| 2 | EDIT US | Editas Medicine Inc | 4,295 | 1,571,540.77 | 0.89 |
| 3 | AVXL US | Anavex Life Sciences Corp | 10,370 | 1,531,419.68 | 0.87 |
| 4 | BEAM US | Beam Therapeutics Inc | 1,810 | 1,504,977.84 | 0.85 |
| 5 | MNKD US | MannKind Corp | 39,688 | 1,397,317.05 | 0.79 |
| 6 | TBIO US | Translate Bio Inc | 7,514 | 1,336,824.41 | 0.76 |
| 7 | OCGN US | Ocugen Inc | 25,352 | 1,315,124.94 | 0.75 |
| 8 | MGNX US | MacroGenics Inc | 7,535 | 1,307,460.29 | 0.74 |
| 9 | MCRB US | Seres Therapeutics Inc | 7,825 | 1,205,624.24 | 0.68 |
| 10 | TWST US | Twist Bioscience Corp | 1,402 | 1,206,853.27 | 0.68 |
2021年1季度
| 序号 | 股票代码 | 股票名称 | 数量（股） | 公允价值（元） | 占基金资产净值比例（%） |
|---|---|---|---|---|---|
| 1 | NTLA US | Intellia Therapeutics Inc | 2,116 | 1,115,935.41 | 0.79 |
| 2 | VCEL US | Vericel Corp | 2,970 | 1,084,156.07 | 0.77 |
| 3 | HGEN US | Humanigen Inc | 8,628 | 1,082,916.07 | 0.77 |
| 4 | CLVS US | Clovis Oncology Inc | 23,343 | 1,076,824.87 | 0.76 |
| 5 | ICPT US | Intercept Pharmaceuticals Inc | 6,599 | 1,000,841.32 | 0.71 |
| 6 | SGMO US | Sangamo Therapeutics Inc | 12,015 | 989,295.74 | 0.70 |
| 7 | AMGN | Amgen Inc | 601 | 982,638.10 | 0.69 |
| 8 | GILD US | Gilead Sciences Inc | 2,252 | 956,431.42 | 0.68 |
| 9 | MGNX US | MacroGenics Inc | 4,593 | 961,296.09 | 0.68 |
| 10 | BIIB US | Biogen Inc | 521 | 957,765.33 | 0.68 |
2020年4季度
| 序号 | 股票代码 | 股票名称 | 数量（股） | 公允价值（元） | 占基金资产净值比例（%） |
|---|---|---|---|---|---|
| 1 | AGIO US | Agios Pharmaceuticals Inc | 3,470 | 981,051.99 | 1.10 |
| 2 | ALXN US | Alexion Pharmaceuticals Inc | 967 | 985,808.51 | 1.10 |
| 3 | SAGE US | Sage Therapeutics Inc | 1,694 | 956,210.65 | 1.07 |
| 4 | IONS US | Ionis Pharmaceuticals Inc | 2,553 | 941,847.26 | 1.05 |
| 5 | TGTX US | TG Therapeutics Inc | 2,767 | 939,189.80 | 1.05 |
| 6 | KOD US | Kodiak Sciences Inc | 929 | 890,514.37 | 1.00 |
| 7 | BBIO US | Bridgebio Pharma Inc | 1,906 | 884,356.63 | 0.99 |
| 8 | APLS US | Apellis Pharmaceuticals Inc | 2,354 | 878,569.96 | 0.98 |
| 9 | EDIT US | Editas Medicine Inc | 1,889 | 864,143.34 | 0.97 |
| 10 | ARNA US | Arena Pharmaceuticals Inc | 1,690 | 847,210.63 | 0.95 |
2020年3季度
| 序号 | 股票代码 | 股票名称 | 数量（股） | 公允价值（元） | 占基金资产净值比例（%） |
|---|---|---|---|---|---|
| 1 | IMMU US | Immunomedics Inc | 2,391 | 1,384,539.16 | 1.76 |
| 2 | SRNE US | Sorrento Therapeutics Inc | 15,981 | 1,213,479.12 | 1.55 |
| 3 | BPMC US | Blueprint Medicines Corp | 1,520 | 959,570.33 | 1.22 |
| 4 | NVTA US | Invitae Corp | 3,105 | 916,651.38 | 1.17 |
| 5 | EXAS US | Exact Sciences Corp | 1,325 | 919,933.85 | 1.17 |
| 6 | SGEN US | Seattle Genetics Inc | 674 | 898,218.55 | 1.14 |
| 7 | ARWR US | Arrowhead Pharmaceuticals Inc | 3,042 | 892,044.92 | 1.14 |
| 8 | MRTX US | Mirati Therapeutics Inc | 765 | 865,075.09 | 1.10 |
| 9 | XLRN US | Acceleron Pharma Inc | 1,118 | 856,768.74 | 1.09 |
| 10 | OPK US | OPKO Health Inc | 33,780 | 848,866.71 | 1.08 |
2020年2季度
| 序号 | 股票代码 | 股票名称 | 数量（股） | 公允价值（元） | 占基金资产净值比例（%） |
|---|---|---|---|---|---|
| 1 | INO US | Inovio Pharmaceuticals Inc | 10,450 | 1,993,781.89 | 1.92 |
| 2 | NVTA US | Invitae Corp | 8,414 | 1,804,281.79 | 1.74 |
| 3 | NVAX US | Novavax Inc | 2,986 | 1,761,967.91 | 1.70 |
| 4 | OPK US | OPKO Health Inc | 54,858 | 1,324,332.19 | 1.28 |
| 5 | FOLD US | Amicus Therapeutics Inc | 12,448 | 1,328,934.29 | 1.28 |
| 6 | ARWR US | Arrowhead Pharmaceuticals Inc | 4,157 | 1,271,059.31 | 1.23 |
| 7 | NTRA US | Natera Inc | 3,324 | 1,173,318.38 | 1.13 |
| 8 | ESPR US | Esperion Therapeutics Inc | 3,129 | 1,136,606.57 | 1.10 |
| 9 | ALNY US | Alnylam Pharmaceuticals Inc | 1,085 | 1,137,671.05 | 1.10 |
| 10 | ALKS US | Alkermes PLC | 8,316 | 1,142,432.93 | 1.10 |
2020年1季度
| 序号 | 股票代码 | 股票名称 | 数量（股） | 公允价值（元） | 占基金资产净值比例（%） |
|---|---|---|---|---|---|
| 1 | REGN US | Regeneron Pharmaceuticals Inc | 532 | 1,840,498.41 | 2.63 |
| 2 | MRNA US | Moderna Inc | 8,307 | 1,762,734.97 | 2.52 |
| 3 | GILD US | Gilead Sciences Inc | 3,044 | 1,612,352.24 | 2.31 |
| 4 | VRTX US | Vertex Pharmaceuticals Inc | 914 | 1,540,912.18 | 2.21 |
| 5 | BIIB US | Biogen Inc | 674 | 1,510,827.57 | 2.16 |
| 6 | UTHR US | United Therapeutics Corp | 2,234 | 1,500,900.85 | 2.15 |
| 7 | BMRN US | BioMarin Pharmaceutical Inc | 2,498 | 1,495,529.99 | 2.14 |
| 8 | SGEN US | Seattle Genetics Inc | 1,758 | 1,437,127.80 | 2.06 |
| 9 | EXEL US | Exelixis Inc | 11,238 | 1,371,096.93 | 1.96 |
| 10 | ACAD US | ACADIA Pharmaceuticals Inc | 4,516 | 1,351,844.17 | 1.93 |
